NCT06934473View on ClinicalTrials.gov

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

NARecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Bloodpressure
Interventions
OTHER

GIP(3-30)NH2 / study tool

Selective antagonist of the GIPR, GIP(3-30)NH2

OTHER

Saline (NaCl 0,9 %) (placebo)

Placebo (NaCl 0,9%)

OTHER

GIP(1-42)

Agonist of the GIPR, GIP(1-42)

Trial Locations (2)

2900

NOT_YET_RECRUITING

Center for Clinical Metabolic Research, Copenhagen

RECRUITING

Center for Clinical Metabolic Research, Copenhagen

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER